Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Gavras

Showing results (111-120 of 166) with videos related to

Pageof 17
Sort By:
Clinical Science and Molecular Medicine. Supplement|June 1, 1975
The use of angiotensin-converting enzyme inhibitor in the diagnosis and treatment of hypertensionH Gavras, H R Brunner, J H Laragh, et al.
Agents and Actions. Supplements|January 1, 1987
The antihypertensive contribution of bradykinin as assessed by a specific bradykinin antagonistA Benetos, H Gavras, J M Stewart, et al.
Archives of Internal Medicine|November 1, 1977
Is elevated plasma renin activity of prognostic importance in progressive systemic sclerosis?H Gavras, I Gavras, P J Cannon, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|October 1, 1995
Augmentation of coronary blood flow by ACE inhibition: role of angiotensin and bradykininN A Ruocco, B A Bergelson, T K Yu, et al.
The Journal of Cardiovascular Surgery|January 1, 1976
Proceedings: Changes in blood viscosity and plasma proteins with Raynaud's phenomenonG W Tietjen, S Chien, E C LeRoy, et al.
Current Vascular Pharmacology|August 3, 2013
Sympathetic overactivity in hypertension and cardiovascular diseaseA J Manolis, L E Poulimenos, M S Kallistratos, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1982
Effects of the new oral angiotensin converting enzyme inhibitor MK-421 in human hypertensionH Gavras, J Biollaz, B Waeber, et al.
Journal of Human Stress|September 1, 1978
Studies on the activity of the sympathetic nervous system in essential hypertensionA V Chobanian, H Garvras, I Gavras, et al.
Lancet (London, England)|September 12, 1981
Antihypertensive effect of the new oral angiotensin converting enzyme inhibitor "MK-421"H Gavras, J Biollaz, B Waeber, et al.
Life Sciences|February 14, 1983
Salt-induced hypertension in chronic renal failure: evidence for a neurogenic mechanismD DiPette, B Waeber, L Volicer, et al.
Pageof 17

Showing results (111-120 of 166) with videos related to

Sort By:
Pageof 17
Clinical Science and Molecular Medicine. Supplement|June 1, 1975
The use of angiotensin-converting enzyme inhibitor in the diagnosis and treatment of hypertensionH Gavras, H R Brunner, J H Laragh, et al.
Agents and Actions. Supplements|January 1, 1987
The antihypertensive contribution of bradykinin as assessed by a specific bradykinin antagonistA Benetos, H Gavras, J M Stewart, et al.
Archives of Internal Medicine|November 1, 1977
Is elevated plasma renin activity of prognostic importance in progressive systemic sclerosis?H Gavras, I Gavras, P J Cannon, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|October 1, 1995
Augmentation of coronary blood flow by ACE inhibition: role of angiotensin and bradykininN A Ruocco, B A Bergelson, T K Yu, et al.
The Journal of Cardiovascular Surgery|January 1, 1976
Proceedings: Changes in blood viscosity and plasma proteins with Raynaud's phenomenonG W Tietjen, S Chien, E C LeRoy, et al.
Current Vascular Pharmacology|August 3, 2013
Sympathetic overactivity in hypertension and cardiovascular diseaseA J Manolis, L E Poulimenos, M S Kallistratos, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1982
Effects of the new oral angiotensin converting enzyme inhibitor MK-421 in human hypertensionH Gavras, J Biollaz, B Waeber, et al.
Journal of Human Stress|September 1, 1978
Studies on the activity of the sympathetic nervous system in essential hypertensionA V Chobanian, H Garvras, I Gavras, et al.
Lancet (London, England)|September 12, 1981
Antihypertensive effect of the new oral angiotensin converting enzyme inhibitor "MK-421"H Gavras, J Biollaz, B Waeber, et al.
Life Sciences|February 14, 1983
Salt-induced hypertension in chronic renal failure: evidence for a neurogenic mechanismD DiPette, B Waeber, L Volicer, et al.
Pageof 17